Comparative analyses of various IgE-mediated and non-IgE-mediated inducers of mast cell degranulation for in vitro study
- PMID: 38001385
- DOI: 10.1007/s12026-023-09438-5
Comparative analyses of various IgE-mediated and non-IgE-mediated inducers of mast cell degranulation for in vitro study
Abstract
In vitro investigations of mast cell (MC) degranulation are essential for studying many diseases, particularly allergy and urticaria. Many MC-degranulation inducers are currently available. However, there is no previous systematic comparative analysis of these available inducers in term of their efficacies to induce MC degranulation. Herein, we performed systematic comparisons of efficacies of five well-known and commonly used MC-degranulation inducers. RBL-2H3 cells were sensitized with 50 ng/ml anti-DNP IgE or biotinylated IgE followed by stimulation with 100 ng/ml DNP-BSA or streptavidin, respectively. For non-IgE-mediated inducers, the cells were treated with 5 µg/ml substance P, compound 48/80, or A23187. At 15-, 30-, 45- and 60-min post-induction, several common MC-degranulation markers (including intracellular [Ca2+], β-hexosaminidase release, tryptase expression by immunofluorescence staining, cellular tryptase level by immunoblotting, secretory tryptase level by immunoblotting, CD63 expression by immunofluorescence staining, and CD63 expression by flow cytometry) were evaluated. The data showed that all these markers significantly increased after activation by all inducers. Among them, A23187 provided the greatest degrees of increases in intracellular [Ca2+] and β-hexosaminidase release at all time-points and upregulation of CD63 at one time-point. These data indicate that all these IgE-mediated (anti-DNP IgE/DNP-BSA and biotinylated IgE/streptavidin) and non-IgE-mediated (substance P, compound 48/80, and A23187) inducers effectively induce MC degranulation, while A23187 seems to be the most effective inducer for MC degranulation.
Keywords: A23187; CD63; Compound 48/80; IgE; Non-IgE; RBL-2H3; Substance P; Tryptase; β-hexosaminidase.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells.Cell Tissue Res. 2022 Dec;390(3):413-428. doi: 10.1007/s00441-022-03687-w. Epub 2022 Sep 20. Cell Tissue Res. 2022. PMID: 36125550
-
Correlation between cytosolic calcium concentration and degranulation in RBL-2H3 cells in the presence of various concentrations of antigen-specific IgEs.Immunol Lett. 2001 Jan 15;75(3):185-9. doi: 10.1016/s0165-2478(00)00311-4. Immunol Lett. 2001. PMID: 11166374
-
Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.Front Immunol. 2022 Oct 6;13:1033794. doi: 10.3389/fimmu.2022.1033794. eCollection 2022. Front Immunol. 2022. PMID: 36275683 Free PMC article.
-
Searching for tryptase in the RBL-2H3 mast cell model: Preparation for comparative mast cell toxicology studies with zebrafish.J Appl Toxicol. 2019 Mar;39(3):473-484. doi: 10.1002/jat.3738. Epub 2018 Oct 30. J Appl Toxicol. 2019. PMID: 30374992 Free PMC article.
-
Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.Toxicol Appl Pharmacol. 2017 Mar 15;319:47-58. doi: 10.1016/j.taap.2017.02.002. Epub 2017 Feb 4. Toxicol Appl Pharmacol. 2017. PMID: 28167223
Cited by
-
The Forgotten Innate Immune Cells: Unraveling Their Prospective Interactions with Nanomaterials.Int J Nanomedicine. 2025 Jun 24;20:8173-8189. doi: 10.2147/IJN.S517249. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40584780 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous